Tailored point-of-care biosensors for liquid biopsy in the field of oncology
In the field of cancer detection, technologies to analyze tumors using biomarkers circulating
in fluids such as blood have developed rapidly based on liquid biopsy. A proactive approach …
in fluids such as blood have developed rapidly based on liquid biopsy. A proactive approach …
Biosensors for the detection of lung cancer biomarkers: A review on biomarkers, transducing techniques and recent graphene-based implementations
Lung cancer remains the leading cause of cancer-related death. In addition to chest X-rays
and computerised tomography, the detection of cancer biomarkers serves as an emerging …
and computerised tomography, the detection of cancer biomarkers serves as an emerging …
Signal amplification strategy design in nanozyme‐based biosensors for highly sensitive detection of trace biomarkers
Nanozymes show great promise in enhancing disease biomarker sensing by leveraging
their physicochemical properties and enzymatic activities. These qualities facilitate signal …
their physicochemical properties and enzymatic activities. These qualities facilitate signal …
Biomarker detection in early diagnosis of cancer: recent achievements in point-of-care devices based on paper microfluidics
B Asci Erkocyigit, O Ozufuklar, A Yardim, E Guler Celik… - Biosensors, 2023 - mdpi.com
Microfluidics is very crucial in lab-on-a-chip systems for carrying out operations in a large-
scale laboratory environment on a single chip. Microfluidic systems are miniaturized devices …
scale laboratory environment on a single chip. Microfluidic systems are miniaturized devices …
A CRISPR-Cas12a-powered magnetic relaxation switching biosensor for the sensitive detection of Salmonella
Magnetic relaxation switching (MRS) biosensors are attractive in the field of food safety
owing to their simplicity and high signal-to-noise ratio. But they are less in sensitivity and …
owing to their simplicity and high signal-to-noise ratio. But they are less in sensitivity and …
[HTML][HTML] Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review
C Nie, I Shaw, C Chen - Journal of Pharmaceutical Analysis, 2023 - Elsevier
With the continuous discovery and research of predictive cancer-related biomarkers, liquid
biopsy shows great potential in cancer diagnosis. Surface-enhanced Raman scattering …
biopsy shows great potential in cancer diagnosis. Surface-enhanced Raman scattering …
Application of various optical and electrochemical nanobiosensors for detecting cancer antigen 125 (CA-125): a review
M Pourmadadi, A Moammeri, A Shamsabadipour… - Biosensors, 2023 - mdpi.com
Nowadays, diagnosing early-stage cancers can be vital for saving patients and dramatically
decreases mortality rates. Therefore, specificity and sensitivity in the detection of cancer …
decreases mortality rates. Therefore, specificity and sensitivity in the detection of cancer …
A label-free electrochemical biosensor for highly sensitive detection of GM2A based on gold nanoparticles/conducting amino-functionalized thiophene polymer layer
In this study, a new immunosensor based on an indium tin oxide (ITO) substrate
functionalized with gold nanoparticles (GNPs)/amino-functionalized thiophene polymer P …
functionalized with gold nanoparticles (GNPs)/amino-functionalized thiophene polymer P …
Amorphous nitrogen-doped carbon nanocages with excellent SERS sensitivity and stability for accurate identification of tumor cells
J Lin, D Zhang, J Yu, T Pan, X Wu, T Chen… - Analytical …, 2023 - ACS Publications
The surface-enhanced Raman scattering (SERS) bioprobe's strategy for identifying tumor
cells always depended on the intensity difference of the Raman signal compared with that of …
cells always depended on the intensity difference of the Raman signal compared with that of …
Metabolomic fingerprinting for the detection of early-stage lung cancer: from the genome to the metabolome
The five-year survival rate of lung cancer patients is very low, mainly because most newly
diagnosed patients present with locally advanced or metastatic disease. Therefore, early …
diagnosed patients present with locally advanced or metastatic disease. Therefore, early …